GlobeNewsWire
21 Jul 2026, 17:51 UTC · 5h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Culper Research alleged that ADMA Biologics engaged in a channel stuffing scheme and used an undisclosed related party distributor to fabricate growth. — Allegations of financial fraud and revenue manipulation typically lead to significant valuation write-downs and loss of investor trust.
-0.80Pomerantz LLP has filed a class action lawsuit against ADMA Biologics alleging securities fraud and unlawful business practices. — Legal action following fraud allegations creates potential for large settlement payouts and prolonged regulatory scrutiny.
-0.50Cantor Fitzgerald downgraded ADMA due to the company's failure to provide specific feedback addressing the fraud claims in the Culper report. — A downgrade from a major analyst based on a lack of transparency suggests poor corporate governance and increases selling pressure.
-0.40Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company is facing a class action lawsuit alleging securities fraud and channel stuffing, alongside a stock price collapse and analyst downgrade.
The company is the subject of a class action lawsuit filed by Pomerantz LLP.
The company is the subject of a class action lawsuit filed by Pomerantz LLP.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
5h ago
